Filing Details

Accession Number:
0001578563-19-000020
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-11 19:36:55
Reporting Period:
2019-06-10
Accepted Time:
2019-06-11 19:36:55
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1534120 Cerecor Inc. CERC Pharmaceutical Preparations (2834) 450705648
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1746282 Pericles Calias C/O Cerecor Inc.
540 Gaither Road, Suite 400
Rockville MD 20850
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-10 4,549 $2.85 49,549 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $4.26 2028-07-16 80,000 80,000 Direct
Common Stock Stock Option (Right to Buy) $6.22 2029-04-01 175,000 175,000 Direct
Common Stock Stock Option (Right to Buy) $4.98 2029-05-24 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2028-07-16 80,000 80,000 Direct
2029-04-01 175,000 175,000 Direct
2029-05-24 25,000 25,000 Direct
Footnotes
  1. These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
  2. One-fourth of the shares subject to the stock option will vest on July 16, 2019, and the remaining three-fourths of the shares subject to the stock option will vest in substantially equal monthly installments over the following 36 months, provided the Reporting Person is then still providing continuous service as an employee, director or consultant.
  3. One-fourth of the shares subject to the stock option will vest on April 1, 2020, and the remaining three-fourths of the shares subject to the stock option will vest in equal monthly installments over the following 36 months.